Search for: "Anda Pharmaceuticals, Inc" Results 321 - 340 of 607
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Generic Drug Preemption Q and A
5 Apr 2012, 11:54 am by Bexis
Mylan Pharmaceuticals, Inc., ___ F. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
D.C. District Court Denies Preliminary Injunction In Generic SEROQUEL Litigation; Dismisses "Premature" Lawsuit Without Prejudice
26 Mar 2012, 1:43 am by FDABlog HPM
Circuit’s 2010 decision in Teva Pharmaceuticals USA, Inc. v. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
“RLD Theory of Liability” Continues to Fall Flat; Multiple Court Decisions Build Momentum in Generic Drug Failure-to-Warn Preemption Litigation
19 Mar 2012, 1:31 am by FDABlog HPM
Wyeth, Inc., No. 09-cv-0854 (W.D. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Hatch-Waxman Watch: AstraZeneca Pharmaceutical LP v. Intellipharmaceutics Corp. (D.N.J. 2012)
23 Feb 2012, 8:46 pm by Patent Docs
("IPC") and Intellipharmaceutics International Inc. [read post]
Patent Docs - http://www.patentdocs.org/
The YASMIN Case: Is it Conceivable (or Not) that Hatch-Waxman Method Patent Infringement Lawsuits are Limited to Information in the “Indications and Usage” Drug Labeling Section?
22 Feb 2012, 5:49 pm by FDABlog HPM
Allergan, Inc., 256 F. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
What is an RLD and Why Does it Matter?
3 Feb 2012, 7:12 am by Michelle Yeary
Mylan, Inc. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
A New Hatch-Waxman DJ Jurisdiction Decision . . . . And an Added Twist
24 Jan 2012, 6:34 pm by FDABlog HPM
  Akorn’s ANDA, which FDA has not yet tentatively approved, contains a Paragraph IV certification to the ‘269 patent; however, according to the court, non-party Teva Pharmaceuticals USA, Inc. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Warner Chilcott Labs. Ireland Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2011)
12 Dec 2011, 9:59 pm by Patent Docs
Mylan Pharmaceuticals Inc., an ANDA case brought before Judge Martini in the New Jersey District Court. [read post]
Patent Docs - http://www.patentdocs.org/
Court Report
11 Dec 2011, 6:14 pm by Patent Docs
Pfizer Inc. et al. v. [read post]
Patent Docs - http://www.patentdocs.org/
NJ District Court Dismisses Patent Use Code Counterclaim as Not Valid Under Current Law; All Eyes Move to the Supreme Court PRANDIN Use Code Case
21 Nov 2011, 5:35 pm by FDABlog HPM
  After having amended ANDA No. 078998 with Paragraph IV certifications to the ‘634 and ‘957 patents, Hoffmann-La Roche, Inc. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
FDA is Sued After Approving Generic Topical Corticosteroid Drug Products; Lawsuit Seeks Withdrawal or Suspension of ANDA Approvals
16 Nov 2011, 5:18 pm by FDABlog HPM
(“Hill”) is seeking declaratory and injunctive relief after FDA approved, on October 17, 2011, three ANDAs submitted by Identi Pharmaceuticals Inc. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Court Report
6 Nov 2011, 9:18 pm by Patent Docs
Breckenridge Pharmaceutical Inc. et al. 1:11-cv-01070; filed November 2, 2011 in the District Court of Delaware • Plaintiffs: Cephalon Inc.; Cephalon France • Defendants: Breckenridge Pharmaceutical Inc.; Natco Pharma Ltd. [read post]
Patent Docs - http://www.patentdocs.org/
Judge Sleet: Motion for Judgment on the Pleadings declaring patent in suit unenforceable GRANTED
4 Nov 2011, 12:26 pm by Pilar G. Kraman
Anchen Pharmaceuticals, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
District of Delaware Rules that API Manufacturer Cannot Be Sued Under Section 271(e)(2)
3 Nov 2011, 9:55 am by Aaron Barkoff
Watson Pharmaceuticals, Inc., 629 F. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Court Report
30 Oct 2011, 8:36 pm by Patent Docs
• Defendants: Torrent Pharmaceuticals Ltd.; Torrent Pharma Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Betelgeuse, Betelgeuse, Betelgeuse! The ANDA “RLD Theory of Liability” Rears Its Ugly Head
27 Oct 2011, 2:42 pm by FDABlog HPM
  Morton Grove Pharmaceuticals, Inc. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
VIAGRA Patent Decision Gives Rise to Dispute Over ANDA Approval, Concern About 180-Day Exclusivity Forfeiture; Court Rigidly Applies Patent Statute
24 Oct 2011, 1:39 pm by FDABlog HPM
District Court for the Eastern District of Virginia that Teva Pharmaceuticals USA, Inc. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Mylan's Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist® Patents
21 Oct 2011, 7:40 am by Phil
., a subsidiary of Mylan Inc. [read post]
Philip Brooks' Patent Infringement Updates - http://www.infringementupdates.com/
ANDA Automatic Stay of FDA Approval Does Not Defeat Standing in Sham Litigation Antitrust Counterclaim
20 Sep 2011, 2:26 pm by Don T. Hibner, Jr.
In support, it cited Andrx Pharmaceuticals, Inc. v. [read post]
Antitrust Law Blog - http://www.antitrustlawblog.com/
Obviousness in Chemical Formulations: (Unclaimed) Purpose of Limitation Leads to Nonobviousness Holding
30 Aug 2011, 10:07 pm by Dennis Crouch
Apotex, Inc. [read post]
Patently-O - http://www.patentlyo.com/patent/